globalbarry. Company Intelligence Engine

Anbio Biotechnology

NNNN CIK 0001982708 · In Vitro & In Vivo Diagnostic Substances (SIC 2835)

Disclosed SEC business address
FRIEDRICH-EBERT-ANLAGE 49, FRANKFURT AM MAIN, 2M, 60308

Anbio Biotechnology (ticker NNNN, CIK 0001982708) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: In Vitro & In Vivo Diagnostic Substances (SIC 2835). Disclosed business address country: Germany. Every item is grounded on the cited public source — no figures are fabricated.

21 exposure relationships mapped 14 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
  • FACT Country of disclosed business address: Germany
  • FACT F-3ASR filed 2026-07-09 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.